Stemtech Corporation
STEK
Rank in Stocks
#33747
Stemtech Corporation is a pioneering company specializing in stem cell... Stemtech Corporation is a pioneering company specializing in stem cell nutrition. It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality. The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$207.74K
Change (1 day)
0.00%
Change (1 year)
-95.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Stemtech Corporation (STEK)
Category
Healthcare
Operating Margin for Stemtech Corporation (STEK)
Operating Margin as of November 2026 TTM: -100.84%
According to Stemtech Corporation's latest financial reports, its current operating margin (TTM) is -100.84%. At the end of 2025 the company had an operating margin of -94.18%.
Operating Margin history for Stemtech Corporation from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -100.84% | 7.07% |
| 2025 | -94.18% | 99.45% |
| 2024 | -47.22% | -44.99% |
| 2023 | -85.84% | -22.09% |
| 2022 | -110.18% | 48.31% |
| 2021 | -74.29% | 127.46% |
| 2020 | -32.66% | -17.98% |
| 2019 | -39.82% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.19% |
DE
|
|
| 19.68% | -100.20% |
DE
|
|
| 13.26% | -100.13% |
JP
|
|
| 17.08% | -100.17% |
CH
|
|
| 14.92% | -100.15% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Stemtech Corporation's operating margin
What is Stemtech Corporation's operating margin?
Stemtech Corporation's operating margin is -100.84%, as of Nov 2026.
What was Stemtech Corporation's operating margin in 2025?
In 2025, Stemtech Corporation's operating margin was -94.18%, compared with -47.22% in 2024.
How has Stemtech Corporation's operating margin changed since 2020?
From 2020 to 2025, Stemtech Corporation's operating margin was highest in 2020 (-32.66%) and lowest in 2022 (-110.18%).
How does Stemtech Corporation's operating margin compare with similar companies?
Stemtech Corporation's operating margin (-100.84%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.